A Research Report on Recent Opportunities for Robot-Assisted Percutaneous Coronary Intervention (PCI) 2022.

Percutaneous Coronary Intervention (PCI), which uses robot assistance to insert a stent, is a non-surgical procedure that lowers the risk of injury and operator fatigue. PCI with robot assist is a medical procedure to treat obstructive Coronary Artery Disease. It aids in the opening up of restricted or blocked blood vessels. Robot-assisted PCI is more successful than traditional PCI and has higher accuracy.

Detail Segmentation

The global robot-assisted percutaneous heart surgery market is segmented based on – Product Type, End-User, and Region. Below is a detailed segmental description.

Request a sample to get more information on the Robot-Assisted Percutaneous Coronary Intervention (PCI) market (Use Corporate email ID to Get Higher Priority): https://market.us/report/robot-assisted-percutaneous-coronary-intervention-pci-market/request-sample/

Based on Product Type:
• Robotic Systems
• Instruments
• Accessories

Based on End-User:
• Hospitals
• Cath Labs
• Other End-Users

Based on Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics –

Global Robot-Assisted Percutaneous Coronary Insulitis (PCI) Market Drivers:
This market’s revenue growth trajectory has been driven by the increasing demand for robotically assisted procedures. There is also a growing determinant, a surging elderly population, and many technological innovations. These factors will be key to boosting this market over the coming years.

Global Robot-Assisted Percutaneous Coronary Injection (PCI) Market Restraints:
A poor reimbursement system and inefficient policies are likely to hinder the market’s continued economic growth in developing and underdeveloped countries. In the future, robotically-assisted procedures could pose a further challenge to this industry due to the high costs involved. Market expansion prospects will also be hampered by a shortage of skilled specialists.

Global Robot-Assisted Percutaneous Coronary Injection (PCI) Market Opportunities:
This market is expected to be a lucrative one due to the rising awareness of the importance of healthy living, the increase in demand for minimally invasive surgery, and the exponential rise in medical tourism.

Competitive Landscape –
The market’s key players are: Stryker Corporation, Medtronic Plc, Intuitive Surgical Inc., Zimmer Biomet, Smith+Nephew Plc, Asensus Surgical US Inc., Medrobotics Corporation, THINK Surgical Inc., Auris Health Inc., CMR Surgical Ltd., Medtech Life Pvt. Ltd., Corindus Inc., Renishaw plc, Medical Devices Business Services Inc., meerecompany Inc., Titan Medical Inc., Venus Concept, Accuray Incorporated, Stereotaxis Inc., and KUKA AG, among others. These industry leaders are now focusing their efforts on mergers, partnerships and acquisitions, product development, collaboration strategies, and other ways to maintain their competitive edge.

The Key Developments
2021
Eric Durand, from Rouen Medical Training Center, France, Rouen, assisted Remi Sabatier, Caen University Hospital, France, in the first remote robotic-assisted PCI procedure in Europe. The 75-mile distance between the two locations was 75 miles.